Research Papers

25 of 208 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
The P2X7 receptor in mucosal adaptive immunity.
Grassi F; Marino R.
Purinergic Signal (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
P2Y<sub>11</sub>/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strateg…
Klaver D; Thurnher M.
Purinergic Signal (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects.
Fishman P; Stemmer SM; Bareket-Samish A; Silverman MH; Kerns WD.
Purinergic Signal (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Emerging roles of the P2X7 receptor in cancer pain.
Wu P; Wang Y; Liu Y; Liu Y; Zhou G; Wu X; Wen Q.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using sel…
Dales MO; Mitchell C; Gurney AM; Drummond RM; Kennedy C.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification of novel proteins involved in P2X7-mediated signaling cascades.
Sassenbach L.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
P2Y1R and P2Y2R: potential molecular triggers in muscle regeneration.
Wang MJ; Yang BR; Jing XY; Wang YZ; Kang L; Ren K; Kang L.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The P2X1 receptor as a therapeutic target.
Bennetts FM; Mobbs JI; Ventura S; Thal DM.
Purinergic Signal (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
The P2 purinoceptors in prostate cancer.
Wang Z; Zhu S; Tan S; Zeng Y; Zeng H.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
P2 purinergic receptor dysregulation in urologic disease.
Maynard JP; Sfanos KS.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Ectonucleotidases as bridge between the ATP and adenosine world: reflections on Geoffrey Burnstock.
Schrader J.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons.
Bartlett R; Ly D; Cashman NR; Sluyter R; Yerbury JJ.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Burnstock oration - purinergic signalling in kidney transplantation.
Dwyer KM.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Second meeting of the Australian and New Zealand Purine Club.
Gubert C; Sophocleous RA; Sluyter R; Vlajkovic SM; Cederholm JME.
Purinergic Signal (Unknown)
Published: 2022
2/6 Transparent
P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells.
Han Y; Bai C; He XM; Ren QL.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Targeting purinergic receptors to attenuate inflammation of dry eye.
Wang JN; Fan H; Song JT.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Enlightening activation gating in P2X receptors.
Sattler C; Benndorf K.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Purinoceptor: a novel target for hypertension.
Li X; Zhu LJ; Lv J; Cao X.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
P2Y12 receptor gene polymorphisms are associated with epilepsy.
Wang Q; Shi NR; Lv P; Liu J; Zhang JZ; Deng BL; Zuo YQ; Yang J; Wang X; Chen X; Hu XM; Liu TT; Liu J.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
MicroRNA: Crucial modulator in purinergic signalling involved diseases.
Guo J; Yang P; Li YF; Tang JF; He ZX; Yu SG; Yin HY.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
P2X7Rs: new therapeutic targets for osteoporosis.
Huang H; He YM; Lin MM; Wang Y; Zhang X; Liang L; He X.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Purinergic modulation of the immune response to infections.
Eberhardt N; Bergero G; Mazzocco Mariotta YL; Aoki MP.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis.
Wu XM; Zhang N; Li JS; Yang ZH; Huang XL; Yang XF.
Purinergic Signal (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
P2X7 receptor: the regulator of glioma tumor development and survival.
Matyśniak D; Chumak V; Nowak N; Kukla A; Lehka L; Oslislok M; Pomorski P.
Purinergic Signal (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity.
Hesse J; Rosse MK; Steckel B; Blank-Landeshammer B; Idel S; Reinders Y; Sickmann A; Sträter N; Schrader J.
Purinergic Signal (Unknown)
Published: 2021
2/6 Transparent
Funding Declared